Skip to content
Agentic OS
Menu

Intelligence / Healthtech & medtech market map / Diagnostics and laboratory products / Clinical laboratories

SubmarketREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Clinical laboratories

Reagents, consumables and automated analysers supplied to hospital and reference laboratories for routine and specialised in-vitro testing.

Market size
$54.6B
$54.6B ($42.0B–$62.0B) · 2025 · Top-down
Growth
+6.2%
$87.0B by 2032
Attractiveness
75 /100
for B2B sellers
Evidence
Medium confidence
2 sources · Top-down
Level
Submarket
Segmented by
Customer type
Buyers
Hospital and reference laboratories
Buying centre
Laboratory medicine leadership, pathologists, procurement, quality, finance
Maturity
Mature
Structure
Moderately concentrated
Buying triggers
  • Lab automation and middleware tenders
  • New analyser platform launches and instrument replacement cycles
  • Hospital group procurement consolidation
  • Menu extension approvals for installed systems
Pains
  • Throughput and turnaround-time pressure from rising volumes [1]
  • Fragmented legacy analyser estates raising cost per result
  • Reagent price erosion in commoditised chemistry and cardiac assays [7]
  • Staffing shortages limiting manual testing capacity
Scores (1–5)
Pain intensity4
Purchasing power4
Reachability4
Growth3
Growth drivers
  • Hospital laboratory test volume growth from chronic disease and aging populations [1]
  • Automation and analyser replacement cycles in hospital labs [8]
  • Immunodiagnostics as the largest technology segment at 28.2% of laboratory diagnostics in 2025 [8]
  • Expansion of diagnostic laboratory networks [10]
Headwinds
  • Instrument capital spending caution limiting new platform placements [7]
  • China pricing reform pressuring cardiac and clinical chemistry reagent pricing [7]
  • Budget pressure on hospital labs to reduce cost per test
Trends
  • Reagent-rental and instrument-placement models sustaining recurring revenue [7]
  • Consolidation of laboratory networks increasing buyer power [10]
  • Menu expansion on installed analysers as the main growth lever [7]

Niches 3

Split by customer type.

Niche80/100

Multi-site hospital laboratory groups

Hospital groups and integrated laboratory networks standardising reagents, consumables and automated analysers across multiple hospital sites, where the job is to consolidate purch

—
Hospital and reference laboratories
not sizedOpen
Niche80/100

Routine core-lab testing

Hospital and reference laboratories buying reagents, consumables and automated analysers for high-volume routine in-vitro tests such as haematology, clinical chemistry, immunoassay

—
Hospital and reference laboratories
not sizedOpen
Niche80/100

Specialised and molecular assay testing

Hospital and reference laboratories buying reagents, consumables and automated analysers for lower-volume, higher-complexity in-vitro tests such as molecular panels, infectious dis

—
Hospital and reference laboratories
not sizedOpen

How this was sized

$54.6B ($42.0B–$62.0B) · 2025 · Top-down

Hospital laboratories represented 49.3% of the worldwide laboratory diagnostics market in 2025 [8]. Applied to the laboratory diagnostics market of USD 110.85bn (2025) [8] gives USD 54.6bn; the same market is projected to reach USD 168.67bn by 2032 at 6.18% CAGR [8], implying roughly USD 87bn for the hospital-lab segment by 2032. Range reflects the spread between the USD 110.85bn [8] and USD 115.4bn [6] laboratory/clinical diagnostics bases and the 49.3% end-user share.

Alongside it in Diagnostics and laboratory products

// Sell into Clinical laboratories

AOS finds the biggest accounts in this submarket with a reason to talk now, maps their buying centre and prepares the outreach for your approval.